
### [NCIT:C40242](http://purl.obolibrary.org/obo/NCIT_C40242)
**Label:** Vaginal Squamous Neoplasm

**Subclasses:** [NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma), [NCIT:C7736](http://purl.obolibrary.org/obo/NCIT_C7736) (Vaginal Squamous Cell Carcinoma, Not Otherwise Specified), [NCIT:C128060](http://purl.obolibrary.org/obo/NCIT_C128060) (Vaginal Papillary Carcinoma), [NCIT:C40243](http://purl.obolibrary.org/obo/NCIT_C40243) (Vaginal Keratinizing Squamous Cell Carcinoma), [NCIT:C6325](http://purl.obolibrary.org/obo/NCIT_C6325) (Vaginal Verrucous Carcinoma), [NCIT:C4947](http://purl.obolibrary.org/obo/NCIT_C4947) (Vaginal Condyloma Acuminatum), [NCIT:C6374](http://purl.obolibrary.org/obo/NCIT_C6374) (Vaginal Squamous Papilloma), [NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C32542](http://purl.obolibrary.org/obo/NCIT_C32542) (Esophageal Squamous Cell))) 54.17%
- Thing 52.77%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39803](http://purl.obolibrary.org/obo/NCIT_C39803) (PRCC-TFE3 Fusion Protein Expression))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39801](http://purl.obolibrary.org/obo/NCIT_C39801) (inv(X)(p11;q12)))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 39.52%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 39.52%


